We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMRC icon
2501
Digimarc Corp
DMRC
$137M
$0 ﹤0.01%
11
– –
DPZ icon
2502
Domino's
DPZ
$11.4B
– –
-160
Closed -$38
EBF icon
2503
Ennis
EBF
$550M
$0 ﹤0.01%
45
– –
ECON icon
2504
Columbia Emerging Markets Consumer ETF
ECON
$328M
– –
-150
Closed -$3
EFC
2505
Ellington Financial
EFC
$1.68B
– –
-22
Closed –
EMLC icon
2506
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.76B
$0 ﹤0.01%
+10
New +$335
EQBK icon
2507
Equity Bancshares
EQBK
$1.04B
$0 ﹤0.01%
29
– –
EVN
2508
Eaton Vance Municipal Income Trust
EVN
$422M
– –
-7,232
Closed -$93
EWC icon
2509
iShares MSCI Canada ETF
EWC
$6.13B
– –
-974
Closed -$28
EYE icon
2510
National Vision
EYE
$1.66B
– –
-225
Closed -$5
FDD icon
2511
First Trust STOXX European Select Dividend Income Fund
FDD
$861M
– –
-836
Closed -$10
FET icon
2512
Forum Energy Technologies
FET
$640M
$0 ﹤0.01%
17
– –
FF icon
2513
Future Fuel
FF
$203M
– –
-45
Closed –
FLJH icon
2514
Franklin FTSE Japan Hedged ETF
FLJH
$181M
– –
-4,873
Closed -$116
FLJP icon
2515
Franklin FTSE Japan ETF
FLJP
$3.94B
– –
-4,695
Closed -$117
FOR icon
2516
Forestar Group
FOR
$1.47B
$0 ﹤0.01%
11
– –
FORR icon
2517
Forrester Research
FORR
$185M
$0 ﹤0.01%
19
– –
FSLY icon
2518
Fastly Inc
FSLY
$3.14B
– –
-1,000
Closed -$24
GAIN icon
2519
Gladstone Investment Corp
GAIN
$648M
– –
-45
Closed –
GCOW icon
2520
Pacer Global Cash Cows Dividend ETF
GCOW
$3.34B
– –
-50
Closed -$1
GEM icon
2521
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.66B
– –
-8,000
Closed -$250
GGB icon
2522
Gerdau
GGB
$9.48B
$0 ﹤0.01%
189
– –
GLAD icon
2523
Gladstone Capital
GLAD
$430M
– –
-30
Closed –
GPRO icon
2524
GoPro
GPRO
$119M
$0 ﹤0.01%
200
-266
-57% -$1.1K
HALO icon
2525
Halozyme
HALO
$9.66B
– –
-200
Closed -$3
99 100
101
102 103

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.